Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.

Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.

Item
http://www.wikidata.org/entity/Q46701101
Medical therapy of acromegalySurgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis.Dynamic tests and basal values for defining active acromegaly.Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?What is active acromegaly and which parameters do we have?Management options for persistent postoperative acromegaly.Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.Biochemical investigations in diagnosis and follow up of acromegaly.Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly.Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.Nationwide survey of acromegaly in South Korea.Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.
P2860

Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.

Item
http://www.wikidata.org/entity/Q46701101
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
type
label
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
prefLabel
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Postoperative evaluation of pa ...... hormone-binding protein levels
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921